Andreas Halvorsen acquired 19.4 Million Standard BioTools shares worth $49.7 Million. That's 0.19% of their equity portfolio (72nd largest holding). The investor owns 5.20% of the outstanding Standard BioTools stock. The investor's estimated purchase price is $50.1 Million, resulting in a loss of 0.8%.